In contrast with these studies, our data show that inhibition of CRC cells does not modify ERK content and phosphorylation, thus supporting the conclusion that EIF5A function is not coupled to KRas expression and activity in intestinal tumors. This evidence concerns the gene EIF5A and intestinal neoplasm.